MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, COCP made $2,085,000 in revenue. -$2,049,000 in net income. Net profit margin of -98.27%.

Income Overview

Revenue
$2,085,000
Net Income
-$2,049,000
Net Profit Margin
-98.27%
EPS
-$0.19
Unit: Dollar
Revenue Breakdown
    • General and administrative
    • Research and development
    • Interest income
    • Foreign exchange gain (loss)

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2024-12-31
Stock-based compensation
--160,750
Salaries and personnel costs
--725,000
Research and development
954,000 1,122,000 3,134,250
Other income
---93,500
General and administrative
1,135,000 986,000 -
Total operating expenses
2,089,000 2,108,000 4,469,500
Loss from operations
-2,089,000 -2,108,000 -
Interest income
-22,000 -28,000 -
Foreign exchange gain (loss)
18,000 25,000 -
Insurance
--4,350,000
Total other income, net
40,000 53,000 -
Net loss
-2,049,000 -2,055,000 -4,376,000
Net loss per common share, basic
-0.19 -0.2 -0.43
Net loss per common share, diluted
-0.19 -0.2 -0.43
Weighted average number of common shares, basic
10,991,000 10,174,000 2,543,500
Weighted average number of common shares, diluted
10,991,000 10,174,000 2,543,500
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Foreign exchange gain(loss)$18,000 Interest income-$22,000 Net loss-$2,049,000 Total other income,net$40,000 Loss from operations-$2,089,000 Total operatingexpenses$2,089,000 General andadministrative$1,135,000 Research and development$954,000

Cocrystal Pharma, Inc. (COCP)

Cocrystal Pharma, Inc. (COCP)